Natalya V. Guseva

Publications

• Urothelial Carcinoma with an Rearrangement and Response to Targeted Therapy
  Cold Spring Harbor Molecular Case Studies. Jun, 2019  |   Pubmed ID: 31010895
• Simultaneous Detection of Single-nucleotide Variant, Deletion/insertion, and Fusion in Lung and Thyroid Carcinoma Using Cytology Specimen and an RNA-based Next-generation Sequencing Assay
  Cancer Cytopathology. 03, 2018  |   Pubmed ID: 29364576
• Anchored Multiplex PCR for Targeted Next-generation Sequencing Reveals Recurrent and Novel USP6 Fusions and Upregulation of USP6 Expression in Aneurysmal Bone Cyst
  Genes, Chromosomes & Cancer. 04, 2017  |   Pubmed ID: 27910166
• The NAB2-STAT6 Gene Fusion in Solitary Fibrous Tumor Can Be Reliably Detected by Anchored Multiplexed PCR for Targeted Next-generation Sequencing
  Cancer Genetics. Jul-Aug, 2016  |   Pubmed ID: 27292373
• The Glycophosphatidylinositol Anchor of the MCMV Evasin, M157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor Recognition
  PloS One. 2013  |   Pubmed ID: 23840655
• P53 and the Proteasome Regulate Androgen Receptor Activity
  Cancer Biology & Therapy. May, 2012  |   Pubmed ID: 22407029
• Inhibition of P53 Expression Modifies the Specificity of Chromatin Binding by the Androgen Receptor
  Oncotarget. Feb, 2012  |   Pubmed ID: 22383394
• TOFA (5-tetradecyl-oxy-2-furoic Acid) Reduces Fatty Acid Synthesis, Inhibits Expression of AR, Neuropilin-1 and Mcl-1 and Kills Prostate Cancer Cells Independent of P53 Status
  Cancer Biology & Therapy. Jul, 2011  |   Pubmed ID: 21525791
• KN-93 Inhibits Androgen Receptor Activity and Induces Cell Death Irrespective of P53 and Akt Status in Prostate Cancer
  Cancer Biology & Therapy. Feb, 2010  |   Pubmed ID: 20023417
• Characterization of Murine Cytomegalovirus M157 from Infected Cells and Identification of Critical Residues Mediating Recognition by the NK Cell Receptor Ly49H
  Journal of Immunology (Baltimore, Md. : 1950). Jul, 2008  |   Pubmed ID: 18566392
• Unique Resistance of Breast Carcinoma Cell Line T47D to TRAIL but Not Anti-Fas is Linked to P43cFLIP(L)
  Breast Cancer Research and Treatment. Feb, 2008  |   Pubmed ID: 17453339
• TSA-induced Cell Death in Prostate Cancer Cell Lines is Caspase-2 Dependent and Involves the PIDDosome
  Cancer Biology & Therapy. Sep, 2006  |   Pubmed ID: 17110788
• Mechanisms of Cell Death Induced by Histone Deacetylase Inhibitors in Androgen Receptor-positive Prostate Cancer Cells
  Molecular Cancer Research : MCR. Feb, 2006  |   Pubmed ID: 16513842
• Androgen Regulates Apoptosis Induced by TNFR Family Ligands Via Multiple Signaling Pathways in LNCaP
  Oncogene. Oct, 2005  |   Pubmed ID: 16007156
• Trichostatin A (TSA) Sensitizes the Human Prostatic Cancer Cell Line DU145 to Death Receptor Ligands Treatment
  Cancer Biology & Therapy. Apr, 2005  |   Pubmed ID: 15846101
• Tumor Necrosis Factor-related Apoptosis-inducing Ligand-mediated Activation of Mitochondria-associated Nuclear Factor-kappaB in Prostatic Carcinoma Cell Lines
  Molecular Cancer Research : MCR. Oct, 2004  |   Pubmed ID: 15498932
• Multiple Effects of N-alpha-tosyl-L-phenylalanyl Chloromethyl Ketone (TPCK) on Apoptotic Pathways in Human Prostatic Carcinoma Cell Lines
  Cancer Biology & Therapy. Aug, 2004  |   Pubmed ID: 15197350
• Death Receptor-induced Cell Death in Prostate Cancer
  Journal of Cellular Biochemistry. Jan, 2004  |   Pubmed ID: 14689583
• Overexpression of BAD Potentiates Sensitivity to Tumor Necrosis Factor-related Apoptosis-inducing Ligand Treatment in the Prostatic Carcinoma Cell Line LNCaP
  Molecular Cancer Research : MCR. May, 2003  |   Pubmed ID: 12754297
• Bisindolylmaleimide IX Facilitates Tumor Necrosis Factor Receptor Family-mediated Cell Death and Acts As an Inhibitor of Transcription
  The Journal of Biological Chemistry. Sep, 2002  |   Pubmed ID: 12091392
• Caspase-8 Activation is Necessary but Not Sufficient for Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-mediated Apoptosis in the Prostatic Carcinoma Cell Line LNCaP
  The Prostate. Jun, 2002  |   Pubmed ID: 11992615
• Contribution of Death Receptor and Mitochondrial Pathways to Fas-mediated Apoptosis in the Prostatic Carcinoma Cell Line PC3
  The Prostate. Jun, 2002  |   Pubmed ID: 11987151